Navigation Links
AspenBio Pharma to Present at the Roth Capital Partners 20th Annual Growth Stock Conference
Date:2/14/2008

CASTLE ROCK, Colo., Feb. 14 /PRNewswire-FirstCall/ -- AspenBio Pharma, Inc. (Nasdaq: APPY) an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for animals and humans, has been invited to present at the 20th Annual Roth Capital Partners Growth Stock Conference. The conference will be held February 18-21, 2008 at the Ritz Carlton Laguna Niguel in Dana Point, California.

Roth Capital Partners Stock Conferences are one of the largest in the nation for micro and small-cap companies in technology, healthcare, financial services and consumer products sectors. More than 1,000 institutional investors are expected to attend.

AspenBio's president and CEO, Richard Donnelly, is scheduled to present on Tuesday, February 19 at 3:00 PM Pacific Time (6:00 PM Eastern Time), followed by a break out session and one-on-one meetings. A simultaneous Webcast will be available at http://www.wsw.com/webcast/roth16/appy/.

For more information on the Roth conference, please visit the conference website at http://rothconference.com or call the conference desk at 800-678-9147. For media inquiries and press credentials only call 949-720-5700.

About Roth Capital Partners, LLC

With corporate headquarters in Newport Beach, California and offices in strategic locations in the Western United States and Shanghai, China, Roth Capital Partners, LLC is a full service investment bank serving corporate and institutional clients throughout the world. Offering a wide array of investment banking services including: initial public offerings, follow-ons, PIPEs, private placements, mer
'/>"/>

SOURCE AspenBio Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AspenBio Pharma Closes $18.2 Million Private Placement of Common Stock
2. AspenBio Pharma Announces $18 Million Private Placement of Common Stock
3. AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test
4. AspenBio Pharma to Present at the Oppenheimer Best Ideas 1x1 Conference
5. AspenBio Pharma to Present the Edgewater Research Investor Conference
6. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
7. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
8. AspenBio Pharma Reports Second Quarter 2007 Results
9. Technology Transforms Market Research in Pharmaceutical Industry
10. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast
11. Assured Pharmacy Consolidates Portland, Oregon Pharmacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Albany, New York (PRWEB) August 29, 2014 ... be valued at $5.6 billion in 2019. It ... 18.1% from 2013 to 2019, and was valued ... research report published by Transparency Market Research. , ... please visit: http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research ...
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 Pittcon ... Hub MacDonald, and colleague Koichiro Matsuda, Horiba Scientific, have ... on September 5, 2014. JASIS , Asia’s largest ... 3-5, 2014, in Makuhari Messe, Japan. , The ... Tools for Bioanalysis from Single Molecules to Single Cells” ...
(Date:8/29/2014)... Local veterinarian, Dr. Keith Clement, and his ... to participate in an investigational study of donor stem ... of this study is to determine if a single ... arthritically affected joints can help reduce pain and inflammation ... current investigational study must be older than nine months, ...
(Date:8/29/2014)... 29, 2014 Due to a misstatement posted ... the Adult Stem Cell Technology Center, LLC ( ASCTC ) ... cell therapy research that might benefit ALS patients. Because ... new stem cell technologies and therapeutic applications, FRC listed ASCTC ... Challenge donors who wish not to support research that ...
Breaking Biology Technology:Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3
... SAN FRANCISCO, Jan. 10, 2011 Enobia Pharma Inc., ... II study of ENB-0040, a bone targeted enzyme replacement ... serious, rare metabolic bone disorder. The results were presented ... of Enobia, at the 29th Annual J.P. Morgan Healthcare ...
... (Nasdaq: PRXL ) will release Second Quarter Fiscal ... the close of the stock market.  The announcement will be ... the PR Newswire website at www.prnewswire.com . ... 10:00 a.m. EST on Tuesday, February 1, 2011 to discuss ...
... DuPont (NYSE: DD ) has entered ... a global enzyme and specialty food ingredients company, for ... of Danisco net debt.  Upon closing, this transaction would ... with science-intensive innovations that address global challenges in food ...
Cached Biology Technology:Enobia Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy 2Enobia Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy 3PAREXEL Announces Date of Second Quarter Fiscal Year 2011 Earnings Release and Conference Call 2DuPont to Acquire Danisco for $6.3 Billion 2DuPont to Acquire Danisco for $6.3 Billion 3DuPont to Acquire Danisco for $6.3 Billion 4
(Date:8/28/2014)... MARC (Maximizing Access to Research Careers) Program has announced ... Human Genetics from October 18 22, 2014 in ... promote the entry of students, post doctorates and scientists ... science community and to encourage the participation of young ... This year MARC conferred 16 awards totaling $29,600., The ...
(Date:8/28/2014)... identified the developmental on-off switch for Streptomyces , ... two-thirds of the world,s naturally derived antibiotic medicines. ... it is possible to manipulate this switch to make ... appearing August 28 in Cell , found that ... and a larger protein called BldD ultimately controls whether ...
(Date:8/28/2014)... measuring and imaging how quickly blood flows in the ... drug abuse affects the brain, which may aid in ... better treatment options for recovering drug addicts. The new ... Brook University in New York, USA and the U.S. ... Optical Society,s (OSA) open-access journal Biomedical Optics ...
Breaking Biology News(10 mins):Small molecule acts as on-off switch for nature's antibiotic factory 2Small molecule acts as on-off switch for nature's antibiotic factory 3This is your brain's blood vessels on drugs 2This is your brain's blood vessels on drugs 3
... even a small amount of MDMA, better known as ecstasy, ... study to look at the neurotoxic effects of low doses ... were presented today at the annual meeting of the Radiological ... in blood circulation in some areas of the brain in ...
... India constitute more than one-sixth of the world's ... related to genetic diseases. And with the growth ... and western lifestyles have risen to near-epidemic proportions, ... importance. , In response to this dearth ...
... has yielded new evidence for domesticated horses up to 5,600 ... appear to be the remains of horse corrals beside pit ... by horse manure. The Krasnyi Yar site was inhabited by ... relied heavily on horses for food, tools, and transport. , ...
Cached Biology News:Ecstasy can harm the brains of first-time users 2Researchers make progress in studying genetic traits of India-born populations 2New evidence of early horse domestication 2New evidence of early horse domestication 3
... conserved form of cell suicide, which follows ... component of this process is a cascade ... enzymes participate in a series of reactions ... signals and result in the cleavage of ...
... System provides optimized reagents and protocols for ... genes by insertion of group II introns. ... group II introns and utilizes a simple ... II intron for specific insertion into the ...
Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...
Mouse monoclonal antibody raised against a partial recombinant QARS. NCBI Entrez Gene ID = QARS...
Biology Products: